Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Blood, Tissues, Organs
Blood
Safety Information
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Our Role
Blood
Safety Information
Hospital Blood Bank Annual Report
Blood and Tissues Establishments
Privacy notice - Serious adverse reaction/event reports for blood and blood components
Regulatory Information
Tissues and Cells
Organs
Blood and Tissues Establishments List
Inspection Process
Special Topics
News and Events
Reporting Adverse Reactions / Events
Safety Topics
European Commission issue Rapid Alert to Competent Authorities for Human Tissues and Cells
Notice type:
Warning
Date:
24/10/2008
Product name or type:
Allomatrix Bone Putty and Allomatrix Injectable Putty – Manufactured by Wright Medical Technologies in the USA.
Target Audience:
Tissue Establishments / Orthopaedic Surgeons
Problem Or Issue:
The Belgian Competent Authority for Human Tissues and Cells has notified the European Commission of a recall of two products, Allomatrix Bone Putty and Allomatrix Injectable Putty, which are manufactured by Wright Medical Technologies in the USA and which have been distributed to Tissue Banks in Europe. The European Commission circulated the text of this notification to the Irish Medicines Board and all other Competent Authorities for Human Tissues and Cells and requested that this notification be circulated to all Tissue Banks.
Background Information Or Related Documents:
For more information on this notice please
click here
European Commission issue Rapid Alert to Competent Authorities for Human Tissues and Cells Document
Actions To Be Taken:
The Irish Medicines Board should be notified immediately if either of these products are in use at any Hospital or Clinic in Ireland. Stakeholders are also requested to be aware that the import of such products directly from third countries (i.e. outside the EEA) must be performed by a Tissue Establishment as defined in Commission Directive 2004/23/EC.
If there are any queries in relation to this Rapid Alert, please do not hesitate to contact the Irish Medicines Board.
« Back
Date Printed: 15/10/2024